Clinical features and lipid metabolism genes as potential biomarkers in advanced lung cancer

[31] de Jong PA(2018)Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma Oncol Rep 40 3392-715

[32] Vliegenthart R(2016)The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer J Thorac Oncol 11 39-95

[33] van Ooijen PMA(2010)Performance Status and Smoking Status Are Independent Favorable Prognostic Factors for Survival in Non-small Cell Lung Cancer A Comprehensive Analysis of 26,957 Patients with NSCLC J Thorac Oncol 5 620-93

[34] Peters RB(2012)A call for the aggressive treatment of oligometastatic and oligo-recurrent non-small cell lung cancer Pulmonary med 2012 480961--422

[35] Paesmans M(2011)The Prognostic Impact of Sex on Surgically Resected Non-Small Cell Lung Cancer Depends on Clinicopathologic Characteristics Am J Clin Pathol 135 611-1560

[36] Sculier JP(2006)Survival after resection for primary lung cancer: a population based study of 3211 resected patients Thorax 61 710-269

[37] Lecomte J(2017)Clinical significance of preoperative serum albumin level for prognosis in surgically resected patients with non-small cell lung cancer Comparative study of normal lung, emphysema, and pulmonary fibrosis Lung Cancer 111 88-1232

[38] Thiriaux J(2015)Cachexia Index in Advanced Non-Small-Cell Lung Cancer Patients Clinical Medicine Insights-Oncology 9 87-1220

[39] Libert P(2019)Statin use and prognosis of lung cancer: a systematic review and meta-analysis of observational studies and randomized controlled trials Drug Des Dev Ther 13 405-12

[40] Sergysels B(2007)alpha-methylacyl CoA racemase in pulmonary adenocarcinoma, squamous cell carcinoma, and neuroendocrine tumors - Expression and survival analysis Arch Pathol Lab Med 131 1555-47

[31] de Jong PA(2018)Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma Oncol Rep 40 3392-715

[32] Vliegenthart R(2016)The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer J Thorac Oncol 11 39-95

[33] van Ooijen PMA(2010)Performance Status and Smoking Status Are Independent Favorable Prognostic Factors for Survival in Non-small Cell Lung Cancer A Comprehensive Analysis of 26,957 Patients with NSCLC J Thorac Oncol 5 620-93

[34] Peters RB(2012)A call for the aggressive treatment of oligometastatic and oligo-recurrent non-small cell lung cancer Pulmonary med 2012 480961--422

[35] Paesmans M(2011)The Prognostic Impact of Sex on Surgically Resected Non-Small Cell Lung Cancer Depends on Clinicopathologic Characteristics Am J Clin Pathol 135 611-1560

[36] Sculier JP(2006)Survival after resection for primary lung cancer: a population based study of 3211 resected patients Thorax 61 710-269

[37] Lecomte J(2017)Clinical significance of preoperative serum albumin level for prognosis in surgically resected patients with non-small cell lung cancer Comparative study of normal lung, emphysema, and pulmonary fibrosis Lung Cancer 111 88-1232

[38] Thiriaux J(2015)Cachexia Index in Advanced Non-Small-Cell Lung Cancer Patients Clinical Medicine Insights-Oncology 9 87-1220

[39] Libert P(2019)Statin use and prognosis of lung cancer: a systematic review and meta-analysis of observational studies and randomized controlled trials Drug Des Dev Ther 13 405-12

[40] Sergysels B(2007)alpha-methylacyl CoA racemase in pulmonary adenocarcinoma, squamous cell carcinoma, and neuroendocrine tumors - Expression and survival analysis Arch Pathol Lab Med 131 1555-47